TOOTSIE ROLL INDUSTRIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data TOOTSIE ROLL INDUSTRIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	521	519	519	527	471	571	687	769	723	733
Cost of revenue	322	327	331	330	301	372	454	513	470	474
Gross profit	199	192	188	197	170	199	233	257	253	258
Selling, general and administrative	108	121	118	128	112	132	122	155	153	158
Operating income	91.2	70.4	70.5	69.2	58.2	67.1	111	102	101	101
Interest expense	0.11	0.14	0.18	0.22	0.16	0.05	0.1	0.34	0.51	0.45
Interest income	2.13	2.85	3.54	4.42	4.01	2.74	2.64	5.21	9.6	20.2
Other non-operating income	6.68	14.1	2.72	16.2	18	18.6	-12.6	18.1	26.4	36.3
Pre-tax income	97.9	84.6	73.2	85.4	76.3	85.7	98.1	120	127	137
Income tax	30.6	3.91	16.4	20.6	17.3	20.4	22.2	28	40.1	37.3
Net income to minority interests	-0.19	-0.21	-0.09	-0.08	-0.02	-0.02	-0.05	-0.03	-0.02	-0.07
Net income	67.5	80.9	56.9	64.9	59	65.3	75.9	91.9	86.8	100
EBITDA	111	89.4	89.2	88	76.4	84.7	128	120	119	120
EPS, basic	1.02	1.21	0.84	0.94	0.84	0.91	1.04	1.28	1.18	1.37
EPS, diluted	1.02	1.21	0.84	0.94	0.84	0.91	1.04	1.28	1.18	1.37
Shares, basic (weighted)	66	67	68.1	69.4	70.5	71.5	72.9	71.9	73.4	72.9
Shares, diluted (weighted)	66	67	68.1	69.4	70.5	71.5	72.9	71.9	73.4	72.9

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	119	96.3	111	139	167	106	53.3	75.9	139	127
Short-term investments	67.5	41.6	75.1	100	42.1	40	96.1	95.5	55.8	49.5
Receivables	43	47.4	49.8	45	41.2	54.9	58.6	55.6	43.8	47.9
Other current assets	5.7	12	10.4	6	6.84	7.76	12.1	9.2	10.4	15.1
Total current assets	299	271	304	353	321	268	309	341	334	321
Property, plant and equipment	181	179	186	188	187	209	212	223	220	238
Lease right-of-use assets				1.58	0.86	7.42	4.7	7.15	6.04	5.03
Goodwill	73.2	73.2	73.2	73.2	73.2	73.2	73.2	73.2	73.2	73.2
Long-term investments	165	191	170	153	220	291	248	256	332	437
Total assets	920	931	947	978	985	1,019	1,019	1,084	1,147	1,254
Accounts payable	10.3	11.9	11.8	12.7	13	15	25.2	15.8	13.4	15.9
Accrued liabilities	46.3	45.2	42.8	41.6	45.1	53.9	54.4	61.7	63.6	64.2
Total current liabilities	63.6	63.8	61.4	79.5	70	80	90.1	94.9	87.3	98.5
Lease liabilities				0.52	0.08	6.35	3.95	6.02	4.99	4.25
Total liabilities	209	197	197	218	221	250	236	261	277	313
Paid-in capital	647	657	697	696	707	710	720	737	789	847
Retained earnings	43.8	57.2	33.8	40.8	32.3	39.5	48.3	62.9	57.9	65.5
Treasury stock	-1.99	-1.99	-1.99	-1.99	-1.99	-1.99	-1.99	-1.99	-1.99	-1.99
Other comprehensive income	-20.2	-21.8	-22.2	-20.2	-19.8	-25	-30.2	-23.2	-23.4	-20.5
Shareholders' equity	711	734	751	760	763	769	783	823	871	941
Minority interests	0.17	-0.04	-0.13	-0.21	-0.23	-0.25	-0.29	-0.32	-0.33	-0.4
Total equity	712	734	750	760	763	769	783	823	870	941
Total liabilities and equity	920	931	947	978	985	1,019	1,019	1,084	1,147	1,254

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	67.3	80.7	56.8	64.8	59	65.3	75.9	91.9	86.8	100
Depreciation and amortization	19.6	19	18.7	18.8	18.2	17.6	17.7	18.2	18.2	19.1
Deferred income tax	0.07	-2.48	2.57	2.49	-0.34	-1.27	2.46	-1.22	9.05	11.8
Change in receivables	6.87	-4.01	-2.45	5.09	3.48	-14.1	-3.07	4.89	10.2	-3.29
Change in inventory	4.18	1.56	0.3	-4.38	-0.77	3.94	-28.4	-9.6	15.8	3.42
Change in payables	-2.06	-0.56	1.65	1.08	3.85	10	10.3	-3.57	0.64	-0.45
Cash from operations	98.6	43	101	100	74.7	85.3	72.1	94.6	139	131
Capital expenditures	-16.1	-16.7	-27.6	-20.3	-18	-31.4	-23.4	-26.8	-18	-34.3
Purchases of investments	-81.8	-89.4	-78.4	-67.7	-110	-109	-96.1	-92.4	-109	-134
Cash from investing	-51.9	-9.32	-44.5	-15	9.5	-91.9	-68.6	-14.2	-35.8	-111
Share buybacks	-29.1	-34.1	-19.3	-34.1	-32.1	-30.2	-31.9	-33.1	-13.5	-6.48
Dividends paid	-22.3	-22.6	-23	-23.5	-23.8	-24.1	-24.6	-25.1	-25.5	-26.1
Cash from financing	-51.4	-56.9	-42.4	-57.2	-55.8	-54.1	-56.4	-58.2	-39.1	-32.5
Exchange rate effect	-2.29	0.42	0.5	0.03	-0.45	-0.28
Net change in cash	-7.01	-22.8	14.6	28.1	27.9	-61	-52.6	22.7	62.9	-11.6
Free cash flow	82.5	26.3	73.3	80	56.7	53.9	48.7	67.8	121	96.4
Interest paid	0.03	0.07	0.11	0.12	0.06	0.01	0.08	0.26	0.27	0.2
Income taxes paid	36.4	18.9	5.68	13.9	14.5	22.9	23.9	19.6	38.2	25.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $37.78 on September 28, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	34.5%	Gross profit / revenue.
Operating margin	11.9%	Operating income / revenue.
EBITDA margin	14.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	17.7%	Pre-tax income / revenue.
Net margin	13.0%	Net income / revenue.
FCF margin	10.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	17.0%	Cash from operations / revenue.
Effective tax rate	26.5%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	10.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	7.5%	Net income / average total assets.
Return on invested capital (ROIC)	7.2%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	22.6%	Selling, general and administrative expense / revenue.
Capex / revenue	6.1%	Capital expenditures / revenue.
D&A / revenue	2.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	1.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	2.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	9.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	2.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	3.6%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	8.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	0.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-3.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	11.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	1.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-2.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	9.4%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	15.2%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	9.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	11.1%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	16.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	9.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	10.3%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-6.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	21.9%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	11.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-20.3%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	25.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	11.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	8.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	6.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	4.3%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	9.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	7.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	5.0%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.89x	Current assets / current liabilities.
Quick ratio	1.67x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.22x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	25.0%	Total liabilities / total assets.
Working capital	$219.2M	Current assets - current liabilities.
Goodwill and intangibles / assets	5.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	$879.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.58x	Revenue / average total assets.
Fixed asset turnover	2.97x	Revenue / average property, plant and equipment.
Receivables turnover	14.0x	Revenue / average receivables.
Days sales outstanding	26 days	365 x average receivables / revenue.
Days payables	21 days	365 x average accounts payable / cost of revenue.
FCF conversion	84.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	35.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.27	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$9.79	Revenue / diluted weighted shares.
FCF per share	$1.07	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.66	Cash from operations / diluted weighted shares.
Book value per share	$12.69	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$11.71	Tangible book value / shares outstanding.
Cash per share	$1.88	(Cash + short-term investments) / shares outstanding.
Payout ratio	27.7%	Dividends paid / net income, when net income is positive.
Dividends / FCF	33.0%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$2.84B	Share price x shares outstanding.
Enterprise value	$2.70B	Market cap + total debt - cash - short-term investments.
P/E	29.7x	Market cap / net income. Only when net income is positive.
P/S	3.86x	Market cap / revenue.
P/B	2.98x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.23x	Market cap / tangible book value, when positive.
P/FCF	35.4x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	22.7x	Market cap / cash from operations, when positive.
EV/Sales	3.67x	Enterprise value / revenue.
EV/EBIT	30.9x	Enterprise value / operating income, when both are positive.
EV/EBITDA	25.2x	Enterprise value / EBITDA, when both are positive.
EV/FCF	33.6x	Enterprise value / free cash flow, when both are positive.
FCF yield	2.8%	Free cash flow / market cap.
Earnings yield	3.4%	Net income / market cap (the inverse of P/E).
Dividend yield	0.9%	Dividends paid over the period / market cap.
Shareholder yield	0.9%	(Dividends paid + share buybacks) / market cap.
PEG	3.09x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was TOOTSIE ROLL INDUSTRIES INC's revenue in fiscal 2025?

TOOTSIE ROLL INDUSTRIES INC reported revenue of $732.5M for fiscal 2025, 1.3% higher than the year before.

Was TOOTSIE ROLL INDUSTRIES INC profitable in fiscal 2025?

Yes. Net income was $100.1M, a net margin of 13.7%.

How much free cash flow did TOOTSIE ROLL INDUSTRIES INC generate in fiscal 2025?

Cash from operations of $130.6M minus capital expenditures of $34.3M left free cash flow of $96.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to TOOTSIE ROLL INDUSTRIES INC